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Chikungunya outbreaks occurred in the central province, Sri Lanka in 2006. This community-based study reports the
epidemiology and the natural history of the infection from an aﬀected village. Of the 199 families and 1001 individuals in the
village, 159 (80%) and 513 (51%) were aﬀected, respectively, comprising 237 (46%) males with peak incidence at 40–50 years.
The acute illness caused polyarthritis in 233 (46%), and of them 230 (98%) progressed to chronic arthritic disability (CAD).
Of the CAD patients, 102 (44%) had recovered in 141 days (range 30–210 days) from the disability state whilst 128 (56%) had
persisting disability which lasted 12, 24, and 36 months in 41 (17.8%), 22 (9.5%), and 14 (6.1%) individuals, respectively. Carpal
tunnelsyndrome(CTS)manifestedin110(21%).Femalesshowedpreponderanceforcomplicationsovermales:acutearthritis147
versus 86, P = 0.001; CAD 136 versus 84, P = 0.029; CTS 88 versus 22, P = 0.001; relapses 105 versus 68, P = 0.001. Chikungunya
was highly communicable and caused lasting crippling complications.
1.Introduction
Chikungunya is a crippling mosquito-borne disease caused
by the chikungunya virus that has recently emerged as a
signiﬁcant public health problem in Sri Lanka [1, 2]. In
February 2005, chikungunya infection hit islands of the
southern Indian Ocean aﬀecting up to 200,000 inhabitants
and spread to India in 2006 resulting in 1.38 million
symptomatic illnesses in Central and southern India [3–8].
The worst aﬀected was Reunion Island where 35% of its
inhabitants were aﬀected by the epidemic [9]. First isolated
in Tanzania in 1953, chikungunya virus belongs to the family
Togaviridae,g e n u sAlphavirus with three genotypes: East
African, West African, and Asian [5, 10]. A study showed
that the recent epidemic in South-East Asia has been due
to ﬁve genetically distinct subpopulations of chikungunya
virus strains belonging to East, Central, and South African
(ECSA) lineage and evolutionarily more related to Indian
strain [8].
Chikungunya is a zoonotic disease, and the life cycle
involves primates and Aedes mosquitoes [11]. There is no
eﬀective vaccine to prevent the disease, so that mosquito
control is the appropriate strategy to control and to contain
theinfection[12].Theacutediseaseisself-limiting,andonly
symptomatic treatment is necessary. However, the chronic
phase is crippling for varying time periods. A few studies
haveexaminedthechronicphaseoftheillness,buttheoverall
picture and natural history were not well documented [9, 10,
13, 14]. Thus, studying a cohort of patients from an aﬀected
community with close followup for a long period would
certainly elucidate more information about the infection.
The disease struck Sri Lanka in mid October 2006
aﬀecting many parts of the Island, and there were isolated
pockets of high incidence of infection [2, 15]. One such2 Journal of Tropical Medicine
area was Galagedara-Madige, a village in Kandy District,
Sri Lanka, which was the focus of our study. In this
village a substantial number of inhabitants were aﬀected
by the epidemic, and large numbers have been suﬀering
from its chronic complications even six months after the
infection. The objectives of the study were to describe the
epidemiology, clinical picture, complications, outcome, and
natural history of the chikungunya infection among all
households of the village.
2. Methods
2.1. Subject Enrolment. We carried out a household survey
in Galagedara-Madige, the index village of the study situated
in Kandy District, Sri Lanka, during a period of three
weeks from May to June 2007. At that time seven months
had elapsed from the onset of the epidemic in the village.
The village has been exclusively inhabited by Sri Lankan
Muslims with high population density. The households
of surrounding villages of Galagedara-Madige were also
interviewed for comparison of results.
EthicalclearancewasobtainedfromtheEthicalCommit-
tee, Faculty of Medicine, University of Peradeniya, Sri Lanka.
Permission to interview people in the village was sought
from the local health authorities, Deputy Director of Health
Services, and Medical Oﬃcer of Health-Galagedara.
2.2. Data Collection. Interviewers were three qualiﬁed med-
ical graduates who ﬁrst underwent familiarization with the
data collection sheet and the format of interview. A struc-
tured, interviewer-completed questionnaire was used for the
data collection. In order to avoid interobserver variation,
a common format was agreed upon after deliberations
amongst the team members.
The questionnaire consisted of two parts namely “family
datasheet”and“individualdatasheet.”Partone,“familydata
sheet” was used to collect the demographic data (name, age,
gender, contact details, and number of family members) of
the family and part two, “individual data sheet” was used to
compile data with respect to each patient who presently suf-
fers from chikungunya or had a previous attack. Part two of
the questionnaire contained details such as onset of the dis-
ease, clinical features, disability state, nonarthritic complica-
tions, and past medical history. Where available, the patient’s
clinical notes were inspected to gather more details. Individ-
uals with chronic arthritic disability were followed up peri-
odicallyintheﬁeldat6,12,24,and36monthstillJune2010.
2.3. Diagnosis of Cases and Disability. Though viral diag-
nostic tests are used for the conﬁrmation of the infection,
its availability in an outbreak is limited [5]. Hence, reliance
on clinical data and circumstantial evidence was stressed.
While interviewing the individuals, diagnosis of cases was
madeclinically,consideringtheepidemiologicalandcircum-
stantial evidence. Clinical, laboratory, and serology records
were also examined for the conﬁrmation of the diagnosis,
since local doctors had documented the diagnosis during the
epidemic. Validation of clinical diagnosis was made based on
published data from Kandy district during the same periods
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Figure 1: Temporal relationship of chikungunya incidence in
Madige.
[16]. Diagnosis of chronic arthritic disability was made on
clinical grounds if the patient was having or had arthritic
disability for more than 14 days after the defervescence of the
acute illness.
2.4. Statistical Analysis. All the data collected were coded
andcomputerizedusingMicrosoftExcelSoftware(Microsoft
Oﬃce 2007 Package). Analysis of the data was done using the
statistical package, SPSS version 17.0 for Windows.
Calculation of frequencies and percentages was the ﬁrst
stepintheanalysisofthedemographicdata.Theassociations
betweenratesofchikungunyainfectionandthedemographic
data were then analyzed using the Chi-square test and
“Student’s” t-test. The correlation coeﬃcients between the
number of patients per family and the number of individuals
in the family were also calculated.
The Chi-square test was used to analyze the association
between demographic data and acute illness, disability,
carpal tunnel syndrome, and relapses.
3. Results
3.1. Basic Epidemiological Analysis. Of the 1832 individuals
interviewed in the study, 1001 (55%) were from Galagedara-
Madige (study village), and the rest 831 (45%) were from the
neighboring villages of Galagedara-Madige (Control group).
Of the 1001 individuals of Madige, 513 (51%) were infected
with chikungunya compared to 47 (6%) cases in the control
group (P = 0.000) during the outbreak of chikungunya in
the region from October 2006 to May 2007. The incidence of
cases had peaked during December 2006 to January 2007 in
the study village Madige (Figure 1).
There were 199 families living in Madige, and of them
159 (80%) families were aﬀected during the epidemic.
There was a positive correlation between the numbers of
individualsaﬀectedperfamilyandthetotalnumberoffamily
members. (Pearson’s correlation coeﬃcient = 0.497, P =
0.01) (Figure 2).Journal of Tropical Medicine 3
Table 1: Gender-based analysis of features.
Variable [N]M a l e % F e m a l e % P Valuea
Population of Madige (1001) 485 (48) 516 (52)
Aﬀected people in Madige (513) 237 (46) 276 (54) 0.144
Triad of symptoms (61) 17 (28) 44 (72) 0.002
Arthralgia (430) 191 (44) 239 (56) 0.560
Arthritis (233) 86 (37) 147 (63) 0.000
Chronic arthritic disability (230) 94 (41) 136 (59) 0.029
Carpal tunnel syndrome
Relapses
Present 22 88 0.000
Absent 214 184
Present 68 105 0.000
Absent 166 167
aχ2 statistics.
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Figure 2: Relationship between numbers of aﬀected per family and
number of individuals per family.
The study population of Madige (1001) comprised 485
(49%) males and 516 (52%) females (Table 1).
Of the aﬀected 513 (51%) people, 237 (46%) were males
and 276 (54%) were females (P = 0.144) whilst 160 (31%)
were house wives, 120 (23%) were school students, and 100
(20%) were businessmen. The incidence of the disease had
increased with increasing age and peaked at 40–50 years with
the lowest incidence in children as shown in Table 2.T h e
mean age of the aﬀected group and the nonaﬀected group
was 35 years (range 1–90) and 26 years (range 1–98) (P =
0.000), respectively.
3.2. Analysis of Acute Illness. Of the triad of clinical features
(fever, rash, and joint disease) used for the diagnosis of
chikungunya infection, 100 (20%) had the rash, 233 (46%)
had polyarthritis, and 430 (85%) had arthralgia. Of the
patients with the entire triad (61), the majority were females
(P = 0.002), but the incidence of arthralgia did not show a
signiﬁcant gender-based diﬀerence (P = 0.56) (Table 1).
Among the chikungunya aﬀected 513, there was a single
death, and details of the postmortem could not be traced. Of
the remaining 512, 233 (46%) had polyarthritis comprising
86 (37%) males and 147 (54%) females (P = 0.000). Of
them, 107 (46%) had arthritis along with fever while 114
Table 2: Incidence of chikungunya infection by age group.
Categorized
age
Chikungunya fever [ N,%] ∗
Total
Infected Noninfected
0–12 93 38% 152 62% 245
13–22 74 45% 91 55% 165
23–32 81 51% 78 49% 159
33–42 80 58% 57 42% 137
43–52 76 62% 47 38% 123
53–62 54 59% 38 41% 92
63–72 41 71% 17 29% 58
73–82 12 67% 6 33% 18
83–92 2 67% 1 33% 3
93–102 0 1 100.00% 1
Total 513 51% 488 49% 1001
∗Count, % within categorized age.
(49%) had arthritis at the defervescence, and 12 (5%) had
arthritis before the onset of fever.
Involvement of joints during the acute phase showed
more involvement of weight- bearing joints: ankle 173
(74%), knee joint 96 (41%), and feet 75 (32%) than other
joints: wrist 34 (14%) and back 7 (3%).
3.3. Analysis of Chronic Arthritic Disability. Of the 512
chikungunya-aﬀected group, 230 (45%) had chronic
arthritic disability (CAD) that comprised 99% of
patients who had initial acute polyarthritis with female
preponderance (P = 0.029) (Table 1). Distribution of
the joint involvement was the same as in acute arthritis
with persistent disability in the weight-bearing joints. The
proportion with CAD had increased with advancing age as
shown in Table 3.
Considering the ﬁrst two age categories, the proportion
who had CAD was 10% and 27%, respectively, and this
diﬀerence was signiﬁcant (P = 0.005). The mean ages for the
CAD group and the nondisability group were 44 years (range
2–90 ) and 27 years (range 1–90) (P = 0.000), respectively.4 Journal of Tropical Medicine
Table 3: Distribution of chronic arthritic disability in age groups.
Age category With disability [N, %] Without disability [N,% ] Total
0–12 9 9.9 82 90.1 91
13–22 20 27.0 54 73.0 74
23–32 35 43.2 46 56.8 81
33–42 44 55.7 35 44.3 79
43–52 46 60.5 30 39.5 76
53–62 36 67.9 17 32.1 53
63–72 31 75.6 10 24.4 41
73–82 8 66.7 4 33.3 12
83–92 1 50.0 1 50.0 2
Table 4: Nonarthritic complications among chikungunya-aﬀected
patients.
Complication Number aﬀected [N,% ]
Carpal tunnel syndrome 110 21.5
Postviral fatigue syndrome 8 1.6
Thrombophlebitis 2 0.4
Respiratory tract infections 4 0.8
Calf swelling 1 0.2
Facial swelling 3 0.6
Waxing and waning of chronic arthritis was reported by 204
(89%) patients, and the commonest cause of relapses was
work-related activity.
Of the 230 who complained of CAD 102 (44%) had
recovered from the disability state (recovered group 20%
of 512 patients with chikungunya) whilst 128 (56%) had
persisting disability (persistent group) at the time of the
interview. The mean duration of the disability in the
recovered group was 141 days (range 30–210 days). The
severity of arthritic disability was graded as pain, pain with
swelling, limitation of movements, limitation of function,
andbedridden.Outoftheseﬁvecategories,paininthejoints
was the commonest CAD, and it was found in 59% followed
by limitation of function (31%) of the patients. The outcome
of the persistent group will be assessed periodically over next
three years.
Of the 512 with chikungunya, 34 (7%) patients gave a
past history of arthritic condition. Out of them 21 (64%)
had an exacerbation of arthritis with chikungunya infection,
and 12 (36%) patients remained quiescent (P = 0.037). Also
18 (53%) of them had disability, and 16 (47%) did not have
disability (P = 0.454).
The carpal tunnel syndrome (CTS) was the commonest
nonarthritic complication following the chikungunya infec-
tion (Table 4).
The proportion with CTS had increased with the age. In
the age group of 0–12 years, there were no reported cases of
CTS whilst the incidence increased with age: in 13–22-year
group 5%, 33–42-year group 31%, 43–52-year group 37%,
and 53–62-year group 36%. Furthermore, the incidence of
CTS had signiﬁcantly increased in females, in patients with
past history of arthritis and in the chronic arthritic disability
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Figure 3: Number of individuals with chronic arthritic disability
(CAD) at followup.
group. Subjects with CAD were followed up at 6, 12, 24, and
36 months following the acute clinical illness. The numbers
with the CAD are as follows: 230 (100%), 41 (17.8%), 22
(9.5%), and 14 (6.1%), respectively (Figure 3).
4. Discussion
This survey describes the pattern of spread, prevalence of
long-term sequels, and the natural history of chikungunya
infection which swept across a hamlet in central Sri Lanka
during the recent outbreak of the disease. This village is
a compact mass of houses which is inhabited only by
the Sri Lankan Muslim community who prefers to live as
close extended family, and this fact would have contributedJournal of Tropical Medicine 5
to the higher incidence of the disease compared to the
neighboring villages. The peak of the infection lasted two
months bringing the life in the whole village to a standstill
with economic diﬃculties. We found that the infection had
aﬀected more adults than children and a concurrent sharp
rise of the incidence within households of big families.
Hence, the alarming rapidity of spread of the infection is an
epidemiological feature to be investigated.
Morbidity was more among females as they outnum-
bered the males in acute polyarthritis, chronic arthritic dis-
ability (CAD), carpal tunnel syndrome (CTS), and relapses
of arthritis (Table 1).
Polyarthralgia was the dominant symptom in the acute
stage of the illness and only about 20% gave a history of
a skin rash. Acute polyarthritis aﬀected 45% of the cohort,
and of them 50% of patients had developed arthritis with
the defervescence. Furthermore, weight-bearing joints were
more aﬀected. Interestingly, 99% of patients with acute
polyarthritishadprogressedtoCADwhichwascharacterized
by waxing and waning in severity and very often exacerbated
by physical activities (Table 4). The acute arthritis and
CAD were much less in the paediatric age group (P =
0.001), and what made them less susceptible to these
complications is an open-ended question. The duration of
the CAD varied from 30 to 210 days in the recovered group
accounting for 44% of CAD, but the balance 56%, classiﬁed
aspersistent,groupwouldprobablycontinuewithsymptoms
for hitherto unknown period. At the end of three years of
followup of CAD, we found 6.1% were still suﬀering with
debilities.
The reason why the study population had signiﬁcant
arthritic complications is an unanswered question, and it
needs further research, focusing on genetic studies or HLA
studies to identify any predisposition. The CTS was the
commonest nonarthritic complication (22%) in our study,
and this was commoner in females (P = 0.001), and a
smaller proportion of patients had symptoms suggestive of
a postviral fatigue syndrome.
Chikungunya virus is not a stranger to Sri Lanka as the
ﬁrst epidemic was reported in the early 1960s, followed by
quiescence until the current epidemic which started in mid
October 2006 [2, 17]. There were more than 37, 000 cases
reported in ﬁrst few months from diﬀerent parts of the
island, but this was a tip of the iceberg due to underreporting
[2]. Devastating outbreaks occurred in pockets of close
communities,andonesuchahotspotwastheindexvillageof
ourstudy.Viraltransmissionfromhumantohumanthrough
direct contact with highly viremic blood was postulated in
France [4].
The disease is transmitted by Aedes mosquito, which is
the vector of Dengue fever and chikungunya, found in Sri
Lanka[16].Itisanurbanmosquitoandbreedsinclearwater.
However, overcrowding of houses would have led to poor
hygiene and prevalence of mosquito breeding sites. A study
done in India showed that high population density, lack of
adequate vector control, and poor hygiene were important
risk factors in the population [18].
In the acute illness, we recorded skin manifestation
in 20% of cases, but other studies had observed 40–50%
involvementofskin[6,14].Moredataareavailableonarthri-
tis that had aﬀected 73–80% patients in some published
series and had chronically persisted 4 months and 3 years in
33% and 10% of patients, respectively [6, 10, 14]. Further-
more,inaseriesof47travelersreturningtoFrance,38(81%)
had chronic peripheral rheumatism aﬀecting mainly ankle,
wrist,ﬁngers,andtoesafterthe10thdayofillnesscontraryto
the ﬁndings of our series where 44% of patients had chronic
arthritic debility mainly aﬀecting weight-bearing joints [9].
Further, the same study showed a preponderance of arthritis
to previously injured joints, similar to our observation where
there was a signiﬁcant association between past arthritis
and the CAD [9]. Among the nonarthritic complications,
CTS was the commonest complication (n = 110, 22%). A
previous study showed that 10 out of 47 patients had CTS
[9], but further analysis of the CTS has not been done.
We found that the incidence of CTS was more associated
with females, chikungunya arthritis, past medical history of
arthritic conditions (Table 4), and age.
Interestingly the outbreak of chikungunya in 1965 had
reported less joint disease and nonarthritic complications
than the current series [17]. Furthermore, reemerged infec-
tion appeared to be more severe than the past disease [10].
Plausible explanations for the increased morbidity of the
current infection include mutations of the virus, absence of
herd immunity, lack of vector control, and globalization of
travel and trade [6, 10]. Sri Lanka records high incidence
of chikungunya among the regions during the ongoing
epidemic in the Indian Ocean. A large number was aﬀected
during the epidemic, and they are still suﬀering from its
chroniccomplications.Thishasaﬀectedtheactivitiesofdaily
living and the well-being of the substantial number of people
inthecommunity.Unfortunately,thereisnoevidencebased-
treatment policy for the management of CAD except for its
natural healing and alleviation of symptoms. Hence, proper
understanding of the pathophysiology of chronic disability
and development of an eﬀective treatment regimen would be
an urgent task.
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